This novel mechanism provides an alternative to make viruses like SARS-CoV-2 inactive, promising a new class of peptides as antivirals.

Researchers at the Indian Institute of Sciences in collaboration with scientists from CSIR-Institute of Microbial Technology have exploited this approach to design these peptides.

pll/car/abm